Paper35947710
Bronchiectasis - A Clinical Review.
O'Donnell AE. N Engl J Med, 2022. Cited by 161 papers, by iCite.
Cite this record
ConductScience Library. Bronchiectasis - A Clinical Review. Papers, record 35947710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35947710
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchiectasis | Major topic |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07088926 | A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization | Background |
Source ClinicalTrials.gov
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881832 | Pulmonary Resection for Bronchiectasis: Perioperative and Follow-Up Outcomes in a VATS-Dominant Cohort. | J Clin Med | 2026 | https://conductscience.org/library/papers/42881832 | PubMed |
| 42877568 | Blood remembers the lung: epigenetic signatures of severe bronchiectasis. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42877568 | PubMed |
| 42871578 | Case report of sequential, bilateral, robotic-assisted lung resections for severe bronchiectasis. | AME Case Rep | 2026 | https://conductscience.org/library/papers/42871578 | PubMed |
| 42729290 | Hemoptysis risk in hospitalized patients with bronchiectasis: development and external validation of a clinical prediction model. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42729290 | PubMed |
| 42559356 | Identification of imaging-based pulmonary and extrapulmonary treatable traits in COPD: a review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42559356 | PubMed |
| 42512923 | Exacerbation Burden and Peripheral Airway Dysfunction as Determinants of Quality of Life in Bronchiectasis: Insights from Impulse Oscillometry. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42512923 | PubMed |
| 42481411 | Bronchiectasis in renal transplant patients: a narrative review. | BMJ Open Respir Res | 2026 | https://conductscience.org/library/papers/42481411 | PubMed |
| 42479305 | Age-Specific Considerations in Bronchiectasis Management: Focus on Older Adults with Emphasis on Anti-inflammatory Treatment. | Drugs Aging | 2026 | https://conductscience.org/library/papers/42479305 | PubMed |
| 42474633 | Bronchiectasis in Older Adults: Distinctive Epidemiology, Etiology, Diagnosis, and Clinical Evolution Compared with Younger Populations. | Drugs Aging | 2026 | https://conductscience.org/library/papers/42474633 | PubMed |
| 42473594 | Therapeutic Potential of Ginkgolic Acid C17:1 in Modulating PTEN/mtDNA/TLR9 Axis for Alleviating Chronic Pseudomonas Aeruginosa Infection in Bronchiectasis. | Iran J Biotechnol | 2026 | https://conductscience.org/library/papers/42473594 | PubMed |
| 42276744 | Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies. | Eur Respir J | 2026 | https://conductscience.org/library/papers/42276744 | PubMed |
| 42271136 | An Age-Friendly Approach to Caring for Chronic Lung Disease in the Ambulatory Setting. | Respirology | 2026 | https://conductscience.org/library/papers/42271136 | PubMed |
| 42074699 | Autoantibody Positivity in Bronchiectasis Without Interstitial Lung Diseases: Risk Factors and Impact on Clinical Features. | J Clin Med | 2026 | https://conductscience.org/library/papers/42074699 | PubMed |
| 42051198 | Microbiome and its role in bronchiectasis. | Ther Adv Respir Dis | 2026 | https://conductscience.org/library/papers/42051198 | PubMed |
| 42001165 | Staged surgical management of intralobar pulmonary sequestration with bilateral bronchiectasis in an adolescent: a case report. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42001165 | PubMed |
| 41940032 | Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications. | Front Physiol | 2026 | https://conductscience.org/library/papers/41940032 | PubMed |
| 41938978 | Research progress on clinical challenges and prevention strategies of drug-resistant Nocardia infections. | Front Public Health | 2026 | https://conductscience.org/library/papers/41938978 | PubMed |
| 41881528 | Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app. | BMJ Open | 2026 | https://conductscience.org/library/papers/41881528 | PubMed |
| 41878528 | Lung cancer masquerading in the background of bronchiectasis: a report of two cases and literature review. | Front Oncol | 2026 | https://conductscience.org/library/papers/41878528 | PubMed |
| 41868961 | Effectiveness of exercise training in people with non-cystic fibrosis bronchiectasis with and without COPD. | Front Rehabil Sci | 2026 | https://conductscience.org/library/papers/41868961 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35947710
GET https://conductscience.org/api/papers/v1/35947710/cited_by?page=2